Laupan, Yusop S.

HRN: 21-77-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2022
CEFTRIAXONE 1G (VIAL)
08/05/2022
08/12/2022
2G
IV
Q24h
Appendicitis
Waiting Final Action 
08/05/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/05/2022
08/12/2022
IV
500mg
Q8h
Appendicitis
Waiting Final Action 
08/06/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/06/2022
08/12/2022
IV
750mg
Q8
Liver Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: